Suchowersky, Oksana

Canadian guideline for Parkinson disease

Grimes, D., Fitzpatrick, M., Gordon, J., Miyasaki, J., Fon, E. A., Schlossmacher, M., Suchowersky, O., Rajput, A., Lafontaine, A. L., Mestre, T., et al. (2019) · Canadian Medical Association Journal

Parkinson's Disease Mechanisms and TreatmentsClinical practice guidelines implementation

Cited by 173

Increased Intestinal Permeability and Parkinson Disease Patients: Chicken or Egg?

Salat-Foix, D., Tran, K., Ranawaya, R., Meddings, J., & Suchowersky, O. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

Parkinson's Disease Mechanisms and TreatmentsGastrointestinal motility and disorders

Cited by 80

Sex Differences in Clinical Features of Early, Treated Parkinson’s Disease

Augustine, E. F., Pérez, A., Dhall, R., Umeh, C. C., Videnovic, A., Cambi, F., Wills, A.-M. A., Elm, J. J., Zweig, R. M., Shulman, L. M., et al. (2015) · PLOS ONE

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 71

Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial

Feigin, A., Evans, E. E., Fisher, T. L., Leonard, J. E., Smith, E. S., Reader, A., Mishra, V., Manber, R., Walters, K. A., Kowarski, L., et al. (2022) · Nature Medicine

Genetic Neurodegenerative DiseasesParkinson's Disease Mechanisms and Treatments

Cited by 67

Replication of association between ELAVL4 and Parkinson disease: the GenePD study

DeStefano, A. L., Latourelle, J., Lew, M. F., Suchowersky, O., Klein, C., Golbe, L. I., Mark, M. H., Growdon, J. H., Wooten, G. F., Watts, R., et al. (2008) · Human Genetics

Parkinson's Disease Mechanisms and TreatmentsGenetic Associations and Epidemiology

Cited by 40